Roche公司希望扩展其贫血药物NeoRecormon(倍他依泊汀)的用途，用于包括透析前肾病患者和更多癌症在内的适应症。
基于134个网页-相关网页
Take special care with NeoRecormon 采取特别护理与治疗
Eprex, Roche's NeoRecormon and Amgen's Epogen are all versions of the same hormone, erythropoietin, or EPO.
FORBES: Magazine Article
In addition to Pegasys, we have also lowered our sales expectations from Bonviva and Neorecormon as they continue to lose revenues at an accelerating rate amid generic competition.
FORBES: Roche's Worth $58 On Continued Growth And Strong Pipeline
应用推荐
模块上移
模块下移
不移动